Regeneron Pharmaceuticals Inc (REGN)

Net profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	4,412,600	3,953,600	4,338,400	8,075,300	3,513,200
Revenue	US$ in thousands	14,202,000	13,044,200	12,113,500	16,014,400	8,440,200
Net profit margin		31.07%	30.31%	35.81%	50.43%	41.62%

December 31, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $4,412,600K ÷ $14,202,000K
= 31.07%

Regeneron Pharmaceuticals Inc has experienced fluctuations in its net profit margin over the years. The net profit margin, which indicates the company's profitability, was 41.62% as of December 31, 2020. Subsequently, there was a notable increase to 50.43% by December 31, 2021, signaling a significant improvement in profitability. However, the net profit margin decreased to 35.81% by December 31, 2022, followed by a further decline to 30.31% by December 31, 2023, indicating a potential challenge in maintaining profit levels. As of December 31, 2024, the net profit margin slightly improved to 31.07%. Overall, while Regeneron Pharmaceuticals Inc has shown strong profitability in some years, there have been fluctuations that suggest the need for consistent performance monitoring and management of expenses to sustain profitability levels.